KMG Chemicals’ Chairman Emeritus Is Dumping Shares Fast

in INVESTING IDEAS by

The former CEO of KMG Chemicals sold $0.9 million worth of stock on Wednesday. Not notable at face value but we found huge amounts of insider activity when digging further.


Insider Selling: KMG Chemicals

David Hatcher, the for CEO and now Chairman Emeritus, sold 15,000 shares of KMG Chemicals, Inc. (NYSE: KMG) worth a total of $0.9 million on Wednesday, February 7th.

What’s more interesting is that Mr. Hatcher has sold $39.3 million worth of stock since September 22nd according to recent SEC filings. That’s roughly 4.3% of the company’s total market capitalization. The table below highlights his activity in February alone.

Recent KMG Chemicals, Inc. Insider Transactions
Insider Trading Relationship Date #Shares Value ($)
David Hatcher Chairman Emeritus Feb 07 15,000 $883,650
David Hatcher Chairman Emeritus Feb 06 15,000 $856,500
David Hatcher Chairman Emeritus Feb 05 15,000 $880,950
David Hatcher Chairman Emeritus Feb 02 15,000 $877,500
David Hatcher Chairman Emeritus Feb 01 15,000 $897,600
TOTAL 75,000 $4,396,200

It’s important to note that there is nothing illegal about these transactions as they are being sold pursuant to a 10b5-1 Plan. Rule 10b5-1 is established by the SEC to allow insiders of publicly traded corporations to set up a trading plan for selling stocks they own.

Mr. Hatcher was selling shares in batches of 3,000 but then increased this to batches of 15,000 shares on December 26th. Again, nothing illegal about this but it is newsworthy considering the former CEO and current Chairman Emeritus has cut his total ownership level by nearly 50% in a matter of months.


KMG Chemicals’s Stock Price and Valuation

The company’s shares last traded at $58.88 as of Wednesday, approximately 86.6% of its 52-week high. The stock’s up 56.2% over the last year and 20.7% in the last six months. While the stock is near its high, could the recent insider transactions signal a troubling road ahead for shareholders?

Finbox.io applies pre-built valuation models to calculate a fair value for a given stock and uses consensus Wall Street estimates for the forecast when available. The company’s average fair value of $51.88 implies -11.9% downside and is calculated from 10 separate analyses as shown in the table above.

KMG Chemicals Valuation Detail
Analysis Model Fair Value Upside (Downside)
10-yr DCF Revenue Exit $50.32 -14.5%
5-yr DCF Revenue Exit $49.63 -15.7%
Peer Revenue Multiples $30.47 -48.2%
10-yr DCF EBITDA Exit $68.67 16.6%
5-yr DCF EBITDA Exit $75.79 28.7%
Peer EBITDA Multiples $40.19 -31.7%
10-yr DCF Growth Exit $58.87 0.0%
5-yr DCF Growth Exit $61.82 5.0%
Peer P/E Multiples $46.28 -21.4%
Dividend Discount Model (multi-stage) $36.74 -37.6%
Average $51.88 -11.9%
Median $49.98 -15.1%

While insider activity on its own is not necessarily a buy or sell signal, it may offer insight into how ownership and management feel about a company’s future prospects. Keeping an eye on the activities of insiders and institutions can help investors make more informed investment decisions.

I recommend you continue to research KMG Chemicals to get a more comprehensive view of the company by looking at:

Risk Metrics: how much interest coverage does KMG Chemicals have? This is a ratio used to assess a firm’s ability to pay interest expenses based on operating profits (EBIT). View the company’s interest coverage here.

Efficiency Metrics: how much free cash flow does KMG Chemicals generate as a percentage of total sales? Has it been increasing or decreasing over time? Review the firm’s free cash flow margin here.

Forecast: what is KMG Chemicals’ projected EBITDA margin? Is the company expected to improve its profitability going forward? Analyze the company’s projected EBITDA margin here.


Author: Andy Pai

Expertise: financial modeling, mergers & acquisitions

Andy is a founder at finbox.io, where he’s focused on building tools that make it faster and easier for investors to do investment research. Andy’s background is in investment banking where he led the analysis on over 50 board advisory engagements involving mergers and acquisitions, fairness opinions and solvency opinions. Some of his board advisory highlights:

  • Sears Holdings Corp.’s $620 mm spin-off via rights offering of Sears Outlet, Hometown Stores and Sears Hardware Stores.
  • Cerberus Capital Management’s $3.3 bn acquisition of SUPERVALU Inc.’s New Albertsons, Inc. assets.

Andy can be reached at andy@finbox.io.

As of this writing, I did not hold a position in any of the aforementioned securities and this is not a buy or sell recommendation on any security mentioned.

Expertise: financial modeling, mergers & acquisitions. Andy is also a founder at finbox.io, where he’s focused on building tools that make it faster and easier for investors to do investment research. Andy’s background is in investment banking where he led the analysis on over 50 board advisory engagements involving mergers and acquisitions, fairness opinions and solvency opinions. Some of his board advisory highlights: - Sears Holdings Corp.’s $620 mm spin-off via rights offering of Sears Outlet, Hometown Stores and Sears Hardware Stores. - Cerberus Capital Management’s $3.3 bn acquisition of SUPERVALU Inc.’s New Albertsons, Inc. assets. Andy can be reached at andy@finbox.io or at +1 (516) 778-6257.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.